Transforming growth factor-β blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction

Endocrinology

Volumn 149, Issue 11, 2008, Pages 5828-5834

  Ellmers, Leigh J ^a   Scott, Nicola J A ^a   Medicherla, Satyanarayana ^b   Pilbrow, Anna P ^a   Bridgman, Paul G ^c   Yandle, Timothy G ^a   Richards, A Mark ^a   Protter, Andrew A ^b   Cameron, Vicky A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b SCIOS INC   (United States)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; SD 208; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG MECHANISM; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; CARDIOMEGALY; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION; HEART; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; PTERIDINES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RENIN; RENIN-ANGIOTENSIN SYSTEM; TRANSFORMING GROWTH FACTOR BETA; VENTRICULAR REMODELING;

EID: 54349084035     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0165     Document Type: Article

References (40)

1. Sun Y, Zhang JQ, Zhang J, Ramires FJA 1998 Angiotensin II, transforming growth factor-β1 and repair in the infarcted heart. J Mol Cell Cardiol 30:1559-1569
2. Swynghedauw B 1999 Molecular mechanisms of myocardial remodeling. Physiol Rev 79:215-262
3. Lijnen PJ, Petrov VV, Fagard RH 2000 Induction of cardiac fibrosis by transforming growth factor-β(1). Mol Gen Metab 71:418-435
4. Deten A, Holzl A, Leicht M, Barth W, Zimmer HG 2001 Changes in extracellular matrix and in transforming growth factor β isoforms after coronary artery ligation in rats. J Mol Cell Cardiol 33:1191-1207
5. Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, Dixon IM 1999 Elevation of expression of Smads 2, 3, and 4, decorin and TGF-β in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 31:667-678
6. Takahashi N, Calderone A, Izzo Jr NJ, Maki TM, Marsh JD, Colucci WS 1994 Hypertrophic stimuli induce transforming growth factor-β1 expression in rat ventricular myocytes. J Clin Invest 94:1470-1476
7. Nakajima H, Nakajima HO, Salcher O, Dittie AS, Dembowsky K, Jing S, Field LJ 2000 Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-β(1) transgene in the heart. Circ Res 86:571-579
8. 1. Am J Physiol 283: H1253-H1262
9. Schnee JM, Hsueh WA 2000 Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc Res 46:264-268
10. Yamazaki T, Komuro I, Yazaki Y 1999 Role of the renin-angiotensin system in cardiac hypertrophy. Am J Cardiol 83:53H-57H
11. Rosenkranz S 2004 TGF-β1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63:423-432
12. Cohn JN, Tognoni G 2001 A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345:1667-1675
13. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM 2003 Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349:1893-1906
14. Kim S, Yoshiyama M, Izumi Y, Kawano H, Kimoto M, Zhan Y, Iwao H 2001 Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 103:148-154
15. Nakamura Y, Yoshiyama M, Omura T, Yoshida K, Izumi Y, Takeuchi K, Kim S, Iwao H, Yoshikawa J 2003 Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction. Cardiovasc Res 57:48-54
16. Campbell SE, Katwa LC 1997 Angiotensin II stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 29:1947-1958
17. Lee AA, Dillmann WH, McCulloch AD, Villarreal FJ 1995 Angiotensin II stimulates the autocrine production of transforming growth factor-β1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 27:2347-2357
18. Fujisaki H, Ito H, Hirata Y, Tanaka M, Hata M, Lin M, Adachi S, Akimoto H, Marumo F, Hiroe M 1995 Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest 96:1059-1065
19. Schultz JEJ, Witt SA, Glascock BJ, Nieman ML, Reiser PJ, Nix SL, Kimball TR, Doetschman T 2002 TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest 109:787-796
20. Dennler S, Goumans MJ, ten Dijke P 2002 Transforming growth factor β signal transduction. J Leuk Biol 71:731-740
21. Mehta JL, Attramadal H 2007 The TGFβ superfamily in cardiovascular biology. Cardiovasc Res 74:181-183
22. Bonniaud P, Margetts PJ, Kolb M, Schroeder JA, Kapoun AM, Damm D, Murphy A, Chakravarty S, Dugar S, Higgins L, Protter AA, Gauldie J 2005 Progressive transforming growth factor β1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Resp Crit Care Med 171:889-898
23. Zaiman AL, Podowski M, Medicherla S, Gordy K, Xu F, Zhen L, Shimoda LA, Neptune E, Higgins L, Murphy A, Chakravarty S, Protter A, Sehgal PB, Champion HC, Tuder RM 2008 Role of the TGF-β/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension. Am J Resp Crit Care Med 177:896-905
24. Ellmers LJ, Scott NJ, Piuhola J, Maeda N, Smithies O, Frampton CM, Richards AM, Cameron VA 2007 Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. J Mol Endocrinol 38:245-257
25. Dunn PJ, Espiner EA 1976 Outpatient screening tests for primary aldosteronism. Aust NZ J Med 6:131-135
26. Shi Y, Massague J 2003 Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685-700
27. Bujak M, Frangogiannis NG 2007 The role of TGF-β signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74:184-195
28. Burlew BS, Weber KT 2000 Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin 18:435-442
29. Okada H, Takemura G, Kosai K, Li Y, Takahashi T, Esaki M, Yuge K, Miyata S, Maruyama R, Mikami A, Minatoguchi S, Fujiwara T, Fujiwara H 2005 Postinfarction gene therapy against transforming growth factor-β signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation 111:2430-2437
30. Sun Y, Zhang JQ, Zhang J, Lamparter S 2000 Cardiac remodeling by fibrous tissue after infarction in rats. J Lab Clin Med 135:316-323
31. Zhang D, Gaussin V, Taffet GE, Belaguli NS, Yamada M, Schwartz RJ, Michael LH, Overbeek PA, Schneider MD 2000 TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med 6:556-563
32. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H 1996 Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats. Brit J Pharmacol 118:549-556
33. Yu CM, Tipoe GL, Wing-Hon Lai K, Lau CP 2001 Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. J Am Coll Cardiol 38:1207-1215
34. Martin MM, Buckenberger JA, Jiang J, Malana GE, Knoell DL, Feldman DS, Elton TS 2007 TGF-β1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. Am J Physiol Lung Cell Mol Physiol 293:L790-L799
35. Dahly AJ, Hoagland KM, Flasch AK, Jha S, Ledbetter SR, Roman RJ 2002 Antihypertensive effects of chronic anti-TGF-β antibody therapy in Dahl S rats. Am J Physiol Regul Integr Comp Physiol 283:R757-R767
36. Gordon KJ, Blobe GC 2008 Role of transforming growth factor-β superfamily signaling pathways in human disease. Biochim Biophys Acta 1782:197-228
37. Lavoie P, Robitaille G, Agharazii M, Ledbetter S, Lebel M, Lariviere R 2005 Neutralization of transforming growth factor-β attenuates hypertension and prevents renal injury in uremic rats. J Hypertens 23:1895-1903
38. Kanzaki T, Tamura K, Takahashi K, Saito Y, Akikusa B, Oohashi H, Kasayuki N, Ueda M, Morisaki N 1995 In vivo effect of TGF-β1. Enhanced intimal thickening by administration of TGF-β1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vasc Biol 15:1951-1957
39. Chen X, Ren S, Ma MG, Dharmalingam S, Lu L, Xue M, Ducas J, Shen GX 2003 Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-β in carotid artery of atherosclerotic rabbits. Atherosclerosis 169:31-40
40. Lindner V 2001 Vascular repair processes mediated by transforming growth factor-β. Z Kardiol 90(Suppl 3):17-22